These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7407973)

  • 21. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
    Beisland C; Holsen DS
    Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients.
    Scheibenbogen C; Hunstein W; Keilholz U
    Eur J Cancer; 1994; 30A(8):1209-11. PubMed ID: 7654462
    [No Abstract]   [Full Text] [Related]  

  • 23. Melanoma and vitiligo.
    Lerner AB
    Cancer Immunol Immunother; 1997 Aug; 44(6):352-4. PubMed ID: 9298939
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of immunochemotherapy in malignant melanoma].
    Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
    Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitiligo-like primary melanoma.
    Lugo-Somolinos A; Sánchez JL; Garcia ME
    Am J Dermatopathol; 2008 Oct; 30(5):451-4. PubMed ID: 18806487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasectomy and active specific immunotherapy for a large single melanoma metastasis.
    Baars A; van Riel JM; Cuesta MA; Jaspars EH; Pinedo HM; van den Eertwegh AJ
    Hepatogastroenterology; 2002; 49(45):691-3. PubMed ID: 12063971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma and vitiligo: immunology's Grecian urn.
    Berd D; Mastrangelo MJ; Lattime E; Sato T; Maguire HC
    Cancer Immunol Immunother; 1996 Jun; 42(5):263-7. PubMed ID: 8706046
    [No Abstract]   [Full Text] [Related]  

  • 28. The course of melanoma-associated vitiligo: report of a case.
    Daneshpazhooh M; Shokoohi A; Dadban A; Raafat J
    Melanoma Res; 2006 Aug; 16(4):371-3. PubMed ID: 16845334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
    Brandt O; Christophers E; Fölster-Holst R
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S101-4. PubMed ID: 15858503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
    Moff SL; Corey GR; Gottfredsson M
    Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant melanoma of the vagina].
    Richter P; Sarembe B; Geissler U
    Arch Geschwulstforsch; 1980; 50(2):111-8. PubMed ID: 7436695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer immunotherapy in dermatological view (author's transl)].
    Lübbe D; Gstöttner R
    Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
    Tarhini AA; Land S; Gupta A; Kirkwood JM
    Nat Clin Pract Oncol; 2005 May; 2(5):240-1. PubMed ID: 16264957
    [No Abstract]   [Full Text] [Related]  

  • 36. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
    Cui J; Bystryn JC
    Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimelanoma immunity in vitiligo and melanoma patients.
    Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
    Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
    Kölmel KF; Grange JM; Krone B; Mastrangelo G; Rossi CR; Henz BM; Seebacher C; Botev IN; Niin M; Lambert D; Shafir R; Kokoschka EM; Kleeberg UR; Gefeller O; Pfahlberg A
    Eur J Cancer; 2005 Jan; 41(1):118-25. PubMed ID: 15617996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
    Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.